SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-23-006106
Filing Date
2023-08-14
Accepted
2023-08-14 16:31:27
Documents
71
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vnrx_10q.htm   iXBRL 10-Q 1501408
2 CERTIFICATION vnrx_ex311.htm EX-31.1 13433
3 CERTIFICATION vnrx_ex312.htm EX-31.2 9598
4 CERTIFICATION vnrx_ex321.htm EX-32.1 5131
  Complete submission text file 0001477932-23-006106.txt   7266424

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vnrx-20230630.xsd EX-101.SCH 85963
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE vnrx-20230630_lab.xml EX-101.LAB 404837
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vnrx-20230630_cal.xml EX-101.CAL 51840
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vnrx-20230630_pre.xml EX-101.PRE 365778
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vnrx-20230630_def.xml EX-101.DEF 256877
65 EXTRACTED XBRL INSTANCE DOCUMENT vnrx_10q_htm.xml XML 1319143
Mailing Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014
Business Address 1489 WEST WARM SPRINGS ROAD SUITE 110 HENDERSON NV 89014 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

IRS No.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36833 | Film No.: 231171045
SIC: 2835 In Vitro & In Vivo Diagnostic Substances